M. Azab

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.

A. U. Buzdar, W. Jonat, Anthony Howell et al. · Journal of Clinical Oncology · 1996 · 410 citations · Full text

Pharmacy, Oncology, Pharmacology +16

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *

W. Jonat, Anthony Howell, Carl Blomqvist et al. · European Journal of Cancer · 1996 · 255 citations

Medicine, Oncology, Pharmacology +14

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

David Cunningham, John Zalcberg, U. Räth et al. · European Journal of Cancer · 1995 · 137 citations

Medicine, Oncology, Pharmacology +16

ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study Group.

John Zalcberg, David Cunningham, Eric Van Cutsem et al. · Journal of Clinical Oncology · 1996 · 129 citations

Medicine, Oncology, Pharmacology +12

Effect of Every-Other-Day Fasting on Spontaneous Chromosomal Damage in Rat's Bone-Marrow Cells

M. Azab, Omar F. Khabour, Laila Al-Omari et al. · Journal of Toxicology and Environmental Health · 2009 · 28 citations

Life Sciences, Genetics, Nutritional Sciences +11